1h Free Analyst Time
The generative AI in life sciences market is forecasted to grow by USD 1.05 billion during 2024-2029, accelerating at a CAGR of 20.3% during the forecast period. The report on the generative AI in life sciences market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by imperative to enhance research and development efficiency, proliferation of high volume, multimodal biological data, and advancements in foundational AI and computing infrastructure.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The generative AI in life sciences market is segmented as below:
By Application
- Drug discovery
- Personalized medicine
- Clinical trials
By Technology
- Novel molecule generation
- Protein sequence design
- Synthetic gene design
By Deployment
- Cloud-based
- On-premises
- Hybrid
By Geographical Landscape
- North America
- Europe
- APAC
- Middle East and Africa
- South America
The report on the generative AI in life sciences market covers the following areas:
- Generative AI In Life Sciences Market sizing
- Generative AI In Life Sciences Market forecast
- Generative AI In Life Sciences Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 The Publisher's Analysis
3 Market Landscape
4 Market Sizing
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Technology
8 Market Segmentation by Deployment
9 Customer Landscape
10 Geographic Landscape
11 Drivers, Challenges, and Opportunity/Restraints
12 Competitive Landscape
13 Competitive Analysis
14 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global generative ai in life sciences market: AiCure, Atomwise Inc., BenevolentAI, Boehringer Ingelheim International GmbH, Clarivate PLC, Evogene Ltd., Fujitsu Ltd., Google LLC, Insilico Medicine, International Business Machines Corp., Microsoft Corp., NVIDIA Corp., Owkin Inc., PathAI Inc., Recursion Pharmaceuticals Inc., Sanofi SA, Schrodinger Inc., SOPHiA GENETICS, and Tencent Holdings Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emergence of integrated, closed-loop discovery platforms."
According to the report, one of the major drivers for this market is the imperative to enhance research and development efficiency.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AiCure
- Atomwise Inc.
- BenevolentAI
- Boehringer Ingelheim International GmbH
- Clarivate PLC
- Evogene Ltd.
- Fujitsu Ltd.
- Google LLC
- Insilico Medicine
- International Business Machines Corp.
- Microsoft Corp.
- NVIDIA Corp.
- Owkin Inc.
- PathAI Inc.
- Recursion Pharmaceuticals Inc.
- Sanofi SA
- Schrodinger Inc.
- SOPHiA GENETICS
- Tencent Holdings Ltd.
